Geovax Labs (GOVX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 5,009 | 3,094 | 7,439 | 5,507 | 8,593 |
| Receivables | N/A | 533 | 1,498 | 659 | 548 |
| TOTAL | $6,517 | $5,136 | $10,612 | $7,935 | $10,869 |
| Non-Current Assets | |||||
| PPE Net | 127 | 144 | 150 | 150 | 172 |
| Other Non-Current Assets | 87 | 71 | 71 | 71 | 71 |
| TOTAL | $214 | $215 | $221 | $221 | $243 |
| Total Assets | $6,731 | $5,350 | $10,833 | $8,156 | $11,112 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 976 | 1,830 | 2,403 | 1,850 | 2,148 |
| Accrued Expenses | 848 | 699 | 532 | 1,258 | 460 |
| TOTAL | $1,824 | $2,529 | $2,935 | $3,107 | $2,608 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $1,824 | $2,529 | $2,935 | $3,107 | $2,608 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 29,705 | 25,360 | 15,194 | 13,839 | 9,436 |
| Common Shares | 30 | 16 | 14 | 11 | 9 |
| Retained earnings | -146,402 | -140,084 | -134,714 | -129,356 | -121,093 |
| TOTAL | $4,907 | $2,821 | $7,898 | $5,049 | $8,504 |
| Total Liabilities And Equity | $6,731 | $5,350 | $10,833 | $8,156 | $11,112 |